1092551-88-6

Basic information

• Product Name: 3-(4-((7-hydroxy-6-methyl-2,3-dihydro-1H-inden-4-yl)methyl)-3,5-dimethyl-1H-pyrazol-1-yl)propanoic acid
• Synonyms: 3-(4-((7-hydroxy-6-methyl-2,3-dihydro-1H-inden-4-yl)methyl)-3,5-dimethyl-1H-pyrazol-1-yl)propanoic acid;3-(4-((7-hydroxy-6-Methyl-2,3-dihydro-1H-inden-4-yl)Methyl)-3,5-;4-[(2,3-dihydro-7-hydroxy-6-methyl-1H-inden-4-yl)methyl]-3,5-dimethyl-1H-Pyrazole-1-propanoic acid
• CAS NO: 1092551-88-6
• Molecular Formula: C19H24N2O3
• Molecular Weight: 328.40546
• Mol File: 1092551-88-6.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 3-(4-((7-hydroxy-6-methyl-2,3-dihydro-1H-inden-4-yl)methyl)-3,5-dimethyl-1H-pyrazol-1-yl)propanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-((7-hydroxy-6-methyl-2,3-dihydro-1H-inden-4-yl)methyl)-3,5-dimethyl-1H-pyrazol-1-yl)propanoic acid(1092551-88-6)
• EPA Substance Registry System: 3-(4-((7-hydroxy-6-methyl-2,3-dihydro-1H-inden-4-yl)methyl)-3,5-dimethyl-1H-pyrazol-1-yl)propanoic acid(1092551-88-6)

Safety Data

• Hazardous Substances Data: 1092551-88-6(Hazardous Substances Data)

Usage

General Description

3-(4-((7-hydroxy-6-methyl-2,3-dihydro-1H-inden-4-yl)methyl)-3,5-dimethyl-1H-pyrazol-1-yl)propanoic acid is a chemical compound that belongs to the class of organic compounds known as indanes. It is an acidic compound with a carboxylic acid group and a pyrazole ring. 3-(4-((7-hydroxy-6-methyl-2,3-dihydro-1H-inden-4-yl)methyl)-3,5-dimethyl-1H-pyrazol-1-yl)propanoic acid is also known for its potential pharmaceutical activities, including anti-inflammatory and antioxidant properties. The presence of the hydroxy and methyl groups in its structure suggests that it may have metabolic, cellular, and neurological functions. 3-(4-((7-hydroxy-6-methyl-2,3-dihydro-1H-inden-4-yl)methyl)-3,5-dimethyl-1H-pyrazol-1-yl)propanoic acid has attracted interest in the scientific community due to its potential therapeutic applications, but more research is needed to fully understand its properties and potential uses.

Upstream product

• 1092553-17-7 4-hydroxy-5-methyl-2,3-dihydro-1H-inden-1-one 
• 20294-31-9 5-methyl-2,3-dihydro-1H-inden-4-ol 
• 50-00-0 formaldehyd 
• 4749-07-9 ethyl 3-(3,5-dimethyl-1H-pyrazol-1-yl)propanoate 
• 72145-01-8 3-(3,5-dimethyl-1H-pyrazol-1-yl)propanoic acid 
• 1092551-93-3 3-(4-{[7-(methoxy)-6-methylindan-4-yl]methyl}-3,5-dimethyl-1H-pyrazol-1-yl)propanoic acid 
• 575504-30-2 7-hydroxy-6-methyl-2,3-dihydro-1H-indene-4-carbaldehyde 
• 67-51-6 3,5-dimethyl-1H-pyrazole 

Relevant articles and documents

METHODS OF PRODUCING PYRAZOLE COMPOUNDS

The present invention is directed to methods of producing substituted pyrazole based compounds through novel intermediates and unique processes for preparing such intermediates which enables synthesis of final product through commercially viable route of synthesis. The present invention is also directed to novel methods of producing substituted pyrazole based thyroid like compounds, and solid forms of 3-{4-[(7-hydroxy-6-methyl-indan-4-yl)methyl]-3,5-dimethyl-1H-pyrazol-1-yl}-propanoic acid, its pharmaceutical compositions, and methods of preparation thereof.

NOVEL COMPOUNDS

The present invention discloses a novel thyroid like compounds of formula (I), wherein R1 R2, R3' R4 and Z are as defined in the specification, method for its preparation, composition containing such compounds and use of such compounds and composition as medicament. Further, compounds of formula (I) has significantly low binding affinity to thyroid receptors and thus considerably devoid of thyrotoxic effects. The invention also relates to the use of the compound of formula (I) for the preparation of a medicament for treating various disease conditions such as obesity, dyslipidemia, metabolic syndrome and co-morbidities associated with metabolic syndrome.